On August 27, the Aging in Motion (AIM) Coalition presented an one-hour webinar titled “Stakeholder Perspectives on Sarcopenia Patient-Reported Outcome Measures.” It featured experts Ronenn Roubenoff, M.D., MHS, Novartis Institutes for Biomedical Research, Stephen Joel Coons, Ph.D., The Critical Path Institute, and Wen-Hung Chen, Ph.D., U.S. Food and Drug Administration, and it was moderated by AIM Executive Director Cynthia Bens. The webinar explored diverse stakeholder perspectives on the role of PRO measures in supporting the regulatory assessment of sarcopenia treatments and featured the relevance of PRO measures in capturing changes in mobility and improvements in quality of life for sarcopenic patients. We are pleased to make this webinar available for viewing on demand.
